Loading...
•
Jun 27, 2020
Thermo Fisher Q2 2020 Earnings Report
Thermo Fisher Scientific reported an extraordinary quarter, leveraging its scale and expertise to meet strong global demand for COVID-19 products and services.
Key Takeaways
Thermo Fisher Scientific's second quarter revenue increased by 10% to $6.92 billion, driven by strong demand for COVID-19 related products and services. Adjusted EPS increased 28% to $3.89.
Second quarter revenue increased 10% to $6.92 billion.
Second quarter GAAP diluted earnings per share (EPS) increased 5% to $2.90.
Second quarter adjusted EPS increased 28% to $3.89.
Generated approximately $1.3 billion of COVID-related revenue.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
Thermo Fisher Scientific did not provide GAAP financial measures on a forward-looking basis because they are unable to predict with reasonable certainty and without unreasonable effort items such as the timing and amount of future restructuring actions and acquisition-related charges as well as gains or losses from sales of real estate and businesses, the early retirement of debt and the outcome of legal proceedings.
Revenue & Expenses
Visualization of income flow from segment revenue to net income